The Current Landscape of Antibody-based Therapies in Solid Malignancies

Over the past three decades, monoclonal antibodies (mAbs) have revolutionized the landscape of cancer therapy. Still, this benefit remains restricted to a small proportion of patients due to moderate response rates and resistance emergence. The field has started to embrace better mAb-based formats w...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Ashu, Rauth, Sanchita, Aithal, Abhijit, Kaur, Sukhwinder, Ganguly, Koelina, Orzechowski, Catherine, Varshney, Grish C, Jain, Maneesh, Batra, Surinder K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738893/
https://www.ncbi.nlm.nih.gov/pubmed/33391547
http://dx.doi.org/10.7150/thno.52614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738893/
https://www.ncbi.nlm.nih.gov/pubmed/33391547
http://dx.doi.org/10.7150/thno.52614

Ejemplares similares